Market Movers (8-K)
OID
Antiaging Quantum Living Inc. has changed its independent auditor from PWN LLP to J&S Associate PLT, effective July 25, 2024.
OID
Antiaging Quantum Living Inc. has amended its Certificate of Incorporation to increase its authorized shares from 30 million to 6 billion, split into five classes.
Capital raise
Quarterly Earnings (10-Q)
See all →OID
Antiaging Quantum Living Inc. reported increased revenue for the nine months ended December 31, 2025, but also a higher net loss for the quarter, alongside a significant debt-to-equity conversion.
Capital raise
Worse than expected
OID
Antiaging Quantum Living Inc. reported significantly reduced net losses and strong revenue growth for the six months ended September 30, 2025, driven by its technical support services, despite ongoing going concern issues and reliance on related party funding.
Better than expected
Capital raise
OID
Antiaging Quantum Living Inc. reported a reduced net loss of $133,372 for Q2 2025, driven by increased revenue and lower operating expenses, but continues to face substantial doubt about its ability to continue as a going concern.
Better than expected
Capital raise
OID
Antiaging Quantum Living Inc. reports a significant increase in revenue driven by online platform technical support, but also a widened net loss due to increased operating expenses for the quarter ended December 31, 2024.
Worse than expected
OID
Antiaging Quantum Living Inc. saw a significant increase in revenue but also a substantial rise in net losses for the quarter ended September 30, 2024, compared to the same period last year.
Worse than expected
OID
Antiaging Quantum Living Inc. saw a significant increase in revenue but also a substantial rise in net losses for the quarter ended June 30, 2024, compared to the same period last year.
Worse than expected
Annual Reports (10-K)
OID
Antiaging Quantum Living Inc. files its annual 10-K report, detailing a strategic shift towards proprietary health products and therapy services, alongside financial performance and operational updates.
Worse than expected
OID
Antiaging Quantum Living Inc. (AAQL) reported a dramatic increase in revenue for the fiscal year ended March 31, 2025, driven by new technical support services, but continues to face substantial net losses and a going concern warning.
Worse than expected
Capital raise
OID
Antiaging Quantum Living Inc. has filed an amendment to its annual report to include an omitted auditor's report, while also disclosing material weaknesses in its internal controls and a going concern assessment.
Worse than expected
OID
Antiaging Quantum Living Inc. reports a net loss of $412,971 for the fiscal year ended March 31, 2024, amidst a strategic shift towards global markets and the establishment of new subsidiaries.
Worse than expected
New Public Companies (S-1)
OID
Antiaging Quantum Living Inc. registers 4.28 million Class A Common Stock shares for resale by selling stockholders, following debt conversion, as it expands PRC operations despite recurring losses and going concern doubts.
Capital raise
Worse than expected